1Cross D,Burmester JK.Gene therapy for cancer treatment:past,present and future[J].Clin Med Res,2006,4(3):218-227.
2Butterfield LH.Recent advances in immunothempy for hepatocellular cancer[J].Swiss Mad Wkly,2007,137:83-90.
3V.M,Moiseyenko AO,Danilov IA,et al.Phase Ⅰ/Ⅱ trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors[J].Annals of Oncology,2005,16:162-168.
4Mark E,Dudley,John R,et al.Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes[J].Science,2002,298(5594):850-854.
6Lisa H,Butterfield,Antoni Ribas,et al.A Phase Ⅰ/Ⅱ trialtesting immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four a-fetoprotein peptides[J].Clin Cancer Res,2006,12(9):2817-2825.
7Jan Wierecky,Martin R,Muller,et al.Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients[J].Cancer Res,2006,66(11):5910-5918.
8Scott J,Antonia,Noweeda Mirza,et al.Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer[J].Clin Cancer Res,2006,12(3):878-887.
9Gabriel B,Hanifa B,Olivier M,et al.Naturally acquired MAGE-A10 end SSX-2-Specific CDS+T cell responses in patients with hepatocellular carcinoma[J].The Journal of Immunology,2005,174:1709-1716.
10Catherine M,Bollard,Laura Aguilar,et al.Cytotoxic T lymphocyte therapy for epstein-barr virus Hodgkin's disease[J].J Exp Med,2004,200(12):1623-1633.
二级参考文献8
1Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量：214
